A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children

Study identifier:MI-MA175

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Post Marketing Evaluation of the Effectiveness of the Risk Minimization Plan For Use of FluMist Among Children Less than 5 Years of Age

Medical condition

asthma, immunosuppression

Phase

Phase 4

Healthy volunteers

No

Study drug

No Intervention

Sex

All

Actual Enrollment

321697

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Oct 2007
Primary Completion Date: 01 Mar 2010
Study Completion Date: 01 Mar 2010

Study design

Allocation: Non-randomized
Endpoint Classification: -
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: -

Verification:

Verified 01 Jul 2014 by MedImmune, LLC

Sponsors

MedImmune, LLC

Collaborators

RTI International

Inclusion and exclusion criteria